Kits Eyecare Stock Today
| KTYCF Stock | USD 6.29 0.13 2.02% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Kits Eyecare is trading at 6.29 as of the 12th of March 2025. This is a 2.02 percent decrease since the beginning of the trading day. The stock's lowest day price was 6.29. Kits Eyecare has about a 39 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 12th of December 2024 and ending today, the 12th of March 2025. Click here to learn more.
Kits Eyecare Ltd. operates a digital eyecare platform for eyes in the United States and Canada. The company was incorporated in 2018 and is headquartered in Vancouver, Canada. Kits Eyecare operates under Specialty Retail classification in the United States and is traded on OTC Exchange. The company has 31.29 M outstanding shares. More on Kits Eyecare
Moving together with Kits Pink Sheet
Moving against Kits Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Kits Pink Sheet Highlights
| Business Concentration | Specialty Retail, Consumer Cyclical (View all Sectors) |
Kits Eyecare [KTYCF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Micro-Cap' category with a current market capitalization of 87.29 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Kits Eyecare's market, we take the total number of its shares issued and multiply it by Kits Eyecare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Kits Eyecare classifies itself under Consumer Cyclical sector and is part of Specialty Retail industry. The entity has 31.29 M outstanding shares.
Kits Eyecare has accumulated about 18.89 M in cash with (19.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.6.
Check Kits Eyecare Probability Of Bankruptcy
Ownership AllocationKits Eyecare maintains a total of 31.29 Million outstanding shares. Kits Eyecare secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 76.79 % of Kits Eyecare outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Kits Ownership Details
Kits Eyecare Risk Profiles
| Mean Deviation | 1.8 | |||
| Standard Deviation | 2.94 | |||
| Variance | 8.65 | |||
| Risk Adjusted Performance | 9.0E-4 |
Kits Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Kits Eyecare without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
Kits Eyecare Corporate Management
| Joseph Thompson | CoFounder COO | Profile | |
| Arshil Abdulla | Chief Officer | Profile | |
| Sabrina Liak | President, CoFounder | Profile | |
| Robert Long | Chief Officer | Profile | |
| Stefan Harvalias | Chief Officer | Profile | |
| Roger Hardy | CEO CoFounder | Profile | |
| Tai Silvey | VP Operations | Profile |
Other Information on Investing in Kits Pink Sheet
Kits Eyecare financial ratios help investors to determine whether Kits Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kits with respect to the benefits of owning Kits Eyecare security.